1-15 of 77
Real-World Outcomes with Axatilimab in cGVHD
Project Oncology®Real-World Outcomes with Axatilimab in cGVHD
Brian P. McDonough, MD, FAAFP
Hana Safah, MD
Axatilimab’s Impact on cGVHD and Associated BOS
Project Oncology®Axatilimab’s Impact on cGVHD and Associated BOS
Charles Turck, PharmD, BCPS, BCCCP
Amandeep Salhotra, MD
Interpreting and Applying cGVHD Clinical Trial Data
Project Oncology®Interpreting and Applying cGVHD Clinical Trial Data
Charles Turck, PharmD, BCPS, BCCCP
Christopher Graham, MD
Protecting Immunocompromised Children Through Vaccination
On the Frontlines of ImmunizationsProtecting Immunocompromised Children Through Vaccination
Paul P. Doghramji, MD, FAAFP
Jonathan Albert, MD
Optimizing cGVHD Treatment Decisions in the Second- and Third-Line Settings
Project Oncology®Optimizing cGVHD Treatment Decisions in the Second- and Third-Line Settings
Charles Turck, PharmD, BCPS, BCCCP
Stephanie Gregory, CNP
Real-World Strategies for Complex cGVHD Treatment Decisions
Project Oncology®Real-World Strategies for Complex cGVHD Treatment Decisions
Brian P. McDonough, MD, FAAFP
Doris M. Ponce, MD, MS
- advertisement
Making Mechanism-Based Treatment Decisions in cGVHD
Project Oncology®Making Mechanism-Based Treatment Decisions in cGVHD
Brian P. McDonough, MD, FAAFP
Alicia Lieberman, MD, MS
Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Project Oncology®Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Advancing Relapse Prediction in Pediatric AML Through Genomic MRD
On the Frontlines of AML/ALLAdvancing Relapse Prediction in Pediatric AML Through Genomic MRD
Ryan Quigley
Amanda Winters, MD, PhD
Navigating Genetic Testing in Kidney Transplants: Clinical and Ethical Issues
Clinician's RoundtableNavigating Genetic Testing in Kidney Transplants: Clinical and Ethical Issues
Elisa J. Gordon, PhD, MPH
Consensus and Standards to Improve Continuity of Care in Sickle Cell Disease
Clinician's RoundtableConsensus and Standards to Improve Continuity of Care in Sickle Cell Disease
Patient Case: ATTRwt-CM Discovered Decades After Heart Transplant
Heart MattersPatient Case: ATTRwt-CM Discovered Decades After Heart Transplant
Lily Stern, MD
- advertisement
The Prevalence of End-Stage Kidney and Liver Disease in PLWH
Clinician's RoundtableThe Prevalence of End-Stage Kidney and Liver Disease in PLWH
IDWeek 2023: Investigating the Infectious Risk of Xenotransplantation
Clinician's RoundtableIDWeek 2023: Investigating the Infectious Risk of Xenotransplantation
Jay Fishman, MD
Peter Buch, MD, FACG, AGAF, FACP
Alan Bonder, MD
